On January 21, 2026, the FDA issued a Request for Information (RFI) seeking input on how gluten-related ingredients are disclosed on packaged foods.

The agency is gathering information on non-wheat gluten-containing grains (rye and barley) and oats, due to potential gluten cross-contact. This effort is intended to better understand labeling practices, data gaps, and consumer protection needs—particularly for individuals with celiac disease and gluten sensitivity.

While no regulatory changes have been announced, this RFI could inform future FDA action on gluten labeling. Food manufacturers should review current disclosures and consider engaging in the comment process.

💡 EZFDA Consulting helps companies navigate FDA labeling expectations and prepare regulatory submissions.

#FDA #FoodLabeling #GlutenFree #CeliacDisease #RegulatoryCompliance #EZFDAConsulting